APA aipamena

Rajendram, P., Sacha, G. L., Mehkri, O., Wang, X., Han, X., Vachharajani, V., & Duggal, A. (2021). Tocilizumab in Coronavirus Disease 2019-Related Critical Illness: A Propensity Matched Analysis. Crit Care Explor.

Chicago Style aipamena

Rajendram, Prabalini, Gretchen L. Sacha, Omar Mehkri, Xiaofeng Wang, Xiaozhen Han, Vidula Vachharajani, and Abhijit Duggal. "Tocilizumab in Coronavirus Disease 2019-Related Critical Illness: A Propensity Matched Analysis." Crit Care Explor 2021.

MLA aipamena

Rajendram, Prabalini, et al. "Tocilizumab in Coronavirus Disease 2019-Related Critical Illness: A Propensity Matched Analysis." Crit Care Explor 2021.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.